# EDGAR Filing Document

**Accession Number:** 0001485894
**File Stem:** 0001752724-25-153152
**Filing Date:** 2025-6
**Character Count:** 24438
**Document Hash:** 83c5fd956ddbff49df7f2b2ef7a89ecb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-25-153152.hdr.sgml**: 20250624

**ACCESSION NUMBER**: 0001752724-25-153152

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250430

**FILED AS OF DATE**: 20250624

**DATE AS OF CHANGE**: 20250624

**PERIOD START**: 20251031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** J.P. Morgan Exchange-Traded Fund Trust
- **CENTRAL INDEX KEY:** 0001485894

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22903
- **FILM NUMBER:** 251068135

**BUSINESS ADDRESS:**
- **STREET 1:** 277 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10172
- **BUSINESS PHONE:** (800) 480-4111

**MAIL ADDRESS:**
- **STREET 1:** 277 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10172

## Series and Classes Contracts Data

### JPMorgan Healthcare Leaders ETF (Series ID: S000080528)

| Class ID   | Class Name                      | Ticker Symbol   |
|:---|:---|:---|
| C000243005 | JPMorgan Healthcare Leaders ETF | JDOC            |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** J.P. Morgan Exchange-Traded Fund Trust

- **b. Investment Company Act file number:** 811-22903

- **c. CIK number of Registrant:** 0001485894

- **d. LEI of Registrant:** 5493001E1K1DVWDV2464

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 277 Park Avenue

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10172

  - **Telephone number:** 844-457-6383

**Item A.2. Information about the Series.**

- **a. Name of Series:** JPMorgan Healthcare Leaders ETF

- **b. EDGAR series identifier (if any):** S000080528

- **c. LEI of Series:** 5493000GRVENCXRUA282

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-10-31

- **b. Date as of which information is reported:** 2025-04-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $7809110.49

**Total Liabilities:** $11613.94

**Net Assets:** $7797496.55

**Cash Not Reported:** $64271.58

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000243005 | 0.37%                | -2.93%               | -2.09%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-57478.28               | $79505.63                                  |
| Month 2  | $238986.56               | $-462649.63                                |
| Month 3  | $-33300.72               | $-78415.77                                 |

**Designated Index Information**

- **Index Name:** N/A

- **Index Identifier:** N/A

### Schedule of Portfolio Investments

| Name                                       | Title                                                | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Siemens Healthineers AG                    | Siemens Healthineers AG                              | CUSIP: N/A<br>LEI: 529900QBVWXMWANH7H45       | Long             | EC               | CORP              | DE        |       859 | NS      | $46306.42     | 0.59%             |  |  |  | Yes           |                  2 | On Loan: No      |
| Merus NV                                   | Merus NV                                             | CUSIP: N/A<br>LEI: 549300W8GPUWU8QNU293       | Long             | EC               | CORP              | NL        |       337 | NS      | $15336.87     | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co.                   | Bristol-Myers Squibb Co.                             | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |      4051 | NS      | $203360.20    | 2.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co.                            | Eli Lilly & Co.                                      | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |       895 | NS      | $804560.25    | 10.32%            |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corp.                              | Danaher Corp.                                        | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |      1092 | NS      | $217668.36    | 2.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Stryker Corp.                              | Stryker Corp.                                        | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |       644 | NS      | $240804.48    | 3.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences, Inc.               | Neurocrine Biosciences, Inc.                         | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |       388 | NS      | $41783.72     | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Boston Scientific Corp.                    | Boston Scientific Corp.                              | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |      2992 | NS      | $307787.04    | 3.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Sanofi SA                                  | Sanofi SA                                            | CUSIP: N/A<br>LEI: 549300E9PC51EN656011       | Long             | EC               | CORP              | FR        |      2415 | NS      | $264181.25    | 3.39%             |  |  |  | No            |                  2 | On Loan: No      |
| Soleno Therapeutics, Inc.                  | Soleno Therapeutics, Inc.                            | CUSIP: 834203309<br>LEI: 5493003LCY77N7FXK844 | Long             | EC               | CORP              | US        |       312 | NS      | $23356.32     | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| GSK plc                                    | GSK plc                                              | CUSIP: N/A<br>LEI: 5493000HZTVUYLO1D793       | Long             | EC               | CORP              | GB        |      8694 | NS      | $171990.69    | 2.21%             |  |  |  | No            |                  2 | On Loan: No      |
| Sartorius AG                               | Sartorius AG (Preference)                            | CUSIP: N/A<br>LEI: 529900EQV2DY4FOAMU38       | Long             | EC               | CORP              | DE        |       152 | NS      | $39458.37     | 0.51%             |  |  |  | No            |                  2 | On Loan: No      |
| Argenx SE                                  | Argenx SE                                            | CUSIP: N/A<br>LEI: 7245009C5FZE6G9ODQ71       | Long             | EC               | CORP              | NL        |       185 | NS      | $119593.09    | 1.53%             |  |  |  | No            |                  2 | On Loan: No      |
| Revolution Medicines, Inc.                 | Revolution Medicines, Inc.                           | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |       895 | NS      | $36140.10     | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                          | Johnson & Johnson                                    | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |      3252 | NS      | $508320.12    | 6.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co., Inc.                          | Merck & Co., Inc.                                    | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |       116 | NS      | $9883.20      | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Blueprint Medicines Corp.                  | Blueprint Medicines Corp.                            | CUSIP: 09627Y109<br>LEI: 5299004CC60O9T5HVM83 | Long             | EC               | CORP              | US        |       490 | NS      | $43855.00     | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Twist Bioscience Corp.                     | Twist Bioscience Corp.                               | CUSIP: 90184D100<br>LEI: 549300T23BL59LCOH584 | Long             | EC               | CORP              | US        |       700 | NS      | $26824.00     | 0.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Xenon Pharmaceuticals, Inc.                | Xenon Pharmaceuticals, Inc.                          | CUSIP: 98420N105<br>LEI: 549300XV44Q9Z1MIPQ03 | Long             | EC               | CORP              | CA        |       571 | NS      | $21812.20     | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Novo Nordisk A/S                           | Novo Nordisk A/S, Class B                            | CUSIP: N/A<br>LEI: 549300DAQ1CVT6CXN342       | Long             | EC               | CORP              | DK        |      2341 | NS      | $156522.92    | 2.01%             |  |  |  | No            |                  2 | On Loan: No      |
| Ultragenyx Pharmaceutical, Inc.            | Ultragenyx Pharmaceutical, Inc.                      | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |       603 | NS      | $23504.94     | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Veeva Systems, Inc.                        | Veeva Systems, Inc., Class A                         | CUSIP: 922475108<br>LEI: 549300YZEXPDB92M2F02 | Long             | EC               | CORP              | US        |       426 | NS      | $99551.94     | 1.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Natera, Inc.                               | Natera, Inc.                                         | CUSIP: 632307104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       392 | NS      | $59164.56     | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Exact Sciences Corp.                       | Exact Sciences Corp.                                 | CUSIP: 30063P105<br>LEI: 549300VM3X1FYD4N9Z14 | Long             | EC               | CORP              | US        |       524 | NS      | $23915.36     | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Hoya Corp.                                 | Hoya Corp.                                           | CUSIP: N/A<br>LEI: 353800X4VR3BHEUCJB42       | Long             | EC               | CORP              | JP        |      1000 | NS      | $117666.19    | 1.51%             |  |  |  | No            |                  2 | On Loan: No      |
| McKesson Corp.                             | McKesson Corp.                                       | CUSIP: 58155Q103<br>LEI: 549300WZWOM80UCFSF54 | Long             | EC               | CORP              | US        |       325 | NS      | $231656.75    | 2.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Sarepta Therapeutics, Inc.                 | Sarepta Therapeutics, Inc.                           | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               | CORP              | US        |       288 | NS      | $17971.20     | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Medtronic plc                              | Medtronic plc                                        | CUSIP: N/A<br>LEI: 549300GX3ZBSQWUXY261       | Long             | EC               | CORP              | IE        |      2929 | NS      | $248262.04    | 3.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                                  | Argenx SE                                            | CUSIP: N/A<br>LEI: 7245009C5FZE6G9ODQ71       | Long             | EC               | CORP              | NL        |         6 | NS      | $3878.70      | 0.05%             |  |  |  | No            |                  2 | On Loan: No      |
| Ascendis Pharma A/S                        | Ascendis Pharma A/S                                  | CUSIP: 04351P101<br>LEI: 549300B66JN3W3J8GH73 | Long             | EC               | CORP              | DK        |       255 | NS      | $43462.20     | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Agios Pharmaceuticals, Inc.                | Agios Pharmaceuticals, Inc.                          | CUSIP: 00847X104<br>LEI: 529900ONJHY8EOGYT555 | Long             | EC               | CORP              | US        |      1036 | NS      | $30758.84     | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Cooper Cos., Inc. (The)                    | Cooper Cos., Inc. (The)                              | CUSIP: 216648501<br>LEI: QJKMVPIGLH7530PCUE20 | Long             | EC               | CORP              | US        |       754 | NS      | $61579.18     | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Verona Pharma plc                          | Verona Pharma plc                                    | CUSIP: 925050106<br>LEI: 213800EVI6O6J3TIAL06 | Long             | EC               | CORP              | GB        |       356 | NS      | $25656.92     | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Axsome Therapeutics, Inc.                  | Axsome Therapeutics, Inc.                            | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |       177 | NS      | $19875.33     | 0.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Cardinal Health, Inc.                      | Cardinal Health, Inc.                                | CUSIP: 14149Y108<br>LEI: CCU46N3GJMF4OK4N7U60 | Long             | EC               | CORP              | US        |       641 | NS      | $90566.89     | 1.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals, Inc.               | Vertex Pharmaceuticals, Inc.                         | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |       512 | NS      | $260864.00    | 3.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Roche Holding AG                           | Roche Holding AG                                     | CUSIP: N/A<br>LEI: 549300U41AUUVOAAOB37       | Long             | EC               | CORP              | CH        |       448 | NS      | $146489.96    | 1.88%             |  |  |  | No            |                  2 | On Loan: No      |
| LENZ Therapeutics, Inc.                    | LENZ Therapeutics, Inc.                              | CUSIP: 52635N103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |        63 | NS      | $1796.45      | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Penumbra, Inc.                             | Penumbra, Inc.                                       | CUSIP: 70975L107<br>LEI: 549300RGE06P3ECANU72 | Long             | EC               | CORP              | US        |       190 | NS      | $55639.60     | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Zimmer Biomet Holdings, Inc.               | Zimmer Biomet Holdings, Inc.                         | CUSIP: 98956P102<br>LEI: 2P2YLDVPES3BXQ1FRB91 | Long             | EC               | CORP              | US        |       907 | NS      | $93466.35     | 1.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Takeda Pharmaceutical Co. Ltd.             | Takeda Pharmaceutical Co. Ltd.                       | CUSIP: N/A<br>LEI: 549300ZLMVP4X0OGR454       | Long             | EC               | CORP              | JP        |      3500 | NS      | $105870.20    | 1.36%             |  |  |  | No            |                  2 | On Loan: No      |
| ConvaTec Group plc                         | ConvaTec Group plc                                   | CUSIP: N/A<br>LEI: 213800LS272L4FIDOH92       | Long             | EC               | CORP              | GB        |     11567 | NS      | $40214.52     | 0.52%             |  |  |  | Yes           |                  2 | On Loan: No      |
| IQVIA Holdings, Inc.                       | IQVIA Holdings, Inc.                                 | CUSIP: 46266C105<br>LEI: 549300W3R20NM4KQPH86 | Long             | EC               | CORP              | US        |       491 | NS      | $76139.37     | 0.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Agilent Technologies, Inc.                 | Agilent Technologies, Inc.                           | CUSIP: 00846U101<br>LEI: QUIX8Y7A2WP0XRMW7G29 | Long             | EC               | CORP              | US        |       814 | NS      | $87586.40     | 1.12%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca plc                            | AstraZeneca plc                                      | CUSIP: N/A<br>LEI: PY6ZZQWO2IZFZC3IOL08       | Long             | EC               | CORP              | GB        |      2699 | NS      | $386676.88    | 4.96%             |  |  |  | No            |                  2 | On Loan: No      |
| Amgen, Inc.                                | Amgen, Inc.                                          | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |       161 | NS      | $46838.12     | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Halozyme Therapeutics, Inc.                | Halozyme Therapeutics, Inc.                          | CUSIP: 40637H109<br>LEI: 529900242I3SV9AGM753 | Long             | EC               | CORP              | US        |       846 | NS      | $51961.32     | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Fresenius SE & Co. KGaA                    | Fresenius SE & Co. KGaA                              | CUSIP: N/A<br>LEI: XDFJ0CYCOO1FXRFTQS51       | Long             | EC               | CORP              | DE        |      1679 | NS      | $79747.36     | 1.02%             |  |  |  | No            |                  2 | On Loan: No      |
| JPMorgan U.S. Government Money Market Fund | JPMorgan U.S. Government Money Market Fund, Class IM | CUSIP: 4812C2270<br>LEI: 8I5DZWZKVSZI1NUHU748 | Long             | STIV             | RF                | US        |     52020 | NS      | $52020.04     | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Lonza Group AG                             | Lonza Group AG (Registered)                          | CUSIP: N/A<br>LEI: 549300EFW4H2TCZ71055       | Long             | EC               | CORP              | CH        |       203 | NS      | $145857.38    | 1.87%             |  |  |  | No            |                  2 | On Loan: No      |
| HCA Healthcare, Inc.                       | HCA Healthcare, Inc.                                 | CUSIP: 40412C101<br>LEI: 529900PH4ZGUH2MNEU89 | Long             | EC               | CORP              | US        |       328 | NS      | $113186.24    | 1.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Intuitive Surgical, Inc.                   | Intuitive Surgical, Inc.                             | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |       304 | NS      | $156803.20    | 2.01%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie, Inc.                               | AbbVie, Inc.                                         | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |      1968 | NS      | $383956.80    | 4.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals, Inc.            | Regeneron Pharmaceuticals, Inc.                      | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |       221 | NS      | $132325.96    | 1.70%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group, Inc.                   | UnitedHealth Group, Inc.                             | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |      1232 | NS      | $506894.08    | 6.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific, Inc.             | Thermo Fisher Scientific, Inc.                       | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |       226 | NS      | $96954.00     | 1.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Biohaven Ltd.                              | Biohaven Ltd.                                        | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | VG        |       858 | NS      | $18978.96     | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| CVS Health Corp.                           | CVS Health Corp.                                     | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |      2569 | NS      | $171377.99    | 2.20%             |  |  |  | No            |                  1 | On Loan: No      |
| UCB SA                                     | UCB SA                                               | CUSIP: N/A<br>LEI: 2138008J191VLSGY5A09       | Long             | EC               | CORP              | BE        |       479 | NS      | $87819.46     | 1.13%             |  |  |  | No            |                  2 | On Loan: No      |
| Alkermes plc                               | Alkermes plc                                         | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | IE        |      1195 | NS      | $34380.15     | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-05-30

**Name of Applicant:** J.P. Morgan Exchange-Traded Fund Trust

**Signature:** Timothy J. Clemens

**Name of Signer:** Timothy J. Clemens

**Title:** Treasurer and Principal Financial Officer